RBC Out With Note On QuidelOrtho Saying "After Speaking To Management No Change At QuidelOrtho; Company Withdraws Original Savanna RVP4+ Assay From FDA 510(k) Submission, Plans Resubmission Ahead Of 2024/2025 Respiratory Season
加拿大皇家銀行在QuideLortho上發表了關於QuideLortho的說明說:“在與管理層交談後,QuideLortho沒有變化;公司從FDA提交的510(k)文件中撤回了最初的稀樹草原RVP4+檢測,計劃在2024/2025年呼吸季節之前重新提交